BETAMETHASONE DIPROPIONATE

Post-LOE

betamethasone dipropionate

PharmaIN

ANDATOPICALOINTMENT, AUGMENTED

Approved

Oct 2004

Lifecycle

Post-LOE

Competitive Pressure

30/100

Clinical Trials

Data completeness

4/8 — Partial

BETAMETHASONE DIPROPIONATE (betamethasone dipropionate) by PharmaIN is [see ] . Approved for mild to moderate plaque psoriasis in patients 18 years of age, older, psoriasis. First approved in 2004.

Drug data last refreshed 21h ago

Mechanism of Action

[see ] . Betamethasone dipropionate is a corticosteroid. Corticosteroids play a role in cellular signaling, immune function, inflammation, and protein regulation; however, the precise mechanism of action for the treatment of tinea pedis, tinea cruris and tinea corporis is unknown.

Indications (3)

mild to moderate plaque psoriasis in patients 18 years of age older

Worked on BETAMETHASONE DIPROPIONATE at PharmaIN? Share your interview experience or compensation data (+7 days Pro)

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

Clinical Trials (19)

NCT05882903Phase 2Recruiting

The Effect of Intra-sinus Application of Betamethasone Dipropionate Nasal Cream on Patients with Chronic Rhinosinusitis Post Functional Endoscopic Sinus Surgery (FESS)

Started Aug 2023

24 enrolled

Chronic Rhinosinusitis (Diagnosis)

NCT05811234N/ACompleted

A Study to Assess Treatment Satisfaction, Patient-reported Outcomes, Effectiveness, and Safety of a Fixed-dose Combination of Calcipotriene/Betamethasone Dipropionate PAD Cream in the Treatment of Mild-to-moderate Plaque Psoriasis of the Scalp in Adults

Started Jun 2023

291 enrolled

Plaque Psoriasis

NCT05220293Phase 1/2Terminated

Treatment of Eosinophilic Chronic Rhinosinusitis Utilizing Betamethasone Dipropionate Nasal Cream

Started Feb 2022

2 enrolled

Chronic Rhinosinusitis (Diagnosis)

NCT03898583Phase 1Completed

Clinical Trial to Assess Safety, Tolerability and the Pharmacodynamics Effect of Calcipotriol/Betamethasone Dipropionate in a New Administration Form in Subjects With Chronic Plaque Psoriasis.

Started Apr 2019

15 enrolled

Psoriasis Vulgaris

NCT03442244Phase 1Completed

Skin Irritation of LEO 90100 Foam (Calcipotriol Hydrate Plus Betamethasone Dipropionate) in Healthy Japanese Subjects

Started Jan 2018

20 enrolled

Psoriasis Vulgaris